DocGo Inc.
Data quality: 100%
DCGO
Nasdaq
Services
Health Services
$0.52
▼
$0.06
(-9.88%)
Mkt Cap: 56.71 M
Price
$0.57
Mkt Cap
56.71 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Revenue grew 0.27% annually over 5 years — modest growth
Earnings declined -1465.21% over the past year
Debt/Equity of 0.00 — conservative balance sheet
Generating 29.91 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 48.01%
Capital efficient — spends only 1.41% of revenue on capex
Growth
Revenue Growth (5Y)
0.27%
Below sector avg (3.76%)
Revenue (1Y)-47.74%
Earnings (1Y)-1465.21%
FCF Growth (3Y)N/A
Quality
Return on Equity
-64.25%
Below sector avg (-15.74%)
ROIC-47.81%
Net Margin-56.61%
Op. Margin-55.26%
Safety
Debt / Equity
0.00
Below sector avg (0.39)
Current Ratio2.59
Interest CoverageN/A
Valuation
PE (TTM|2027)
-0.31 | 0.89
Above sector avg (-1.17)
P/B Ratio0.21
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (502 peers)
Peer Comparison
vs Services sector median (502 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.3 | -1.2 |
| P/B | 0.2 | 1.4 |
| ROE % | -64.3 | -15.7 |
| Net Margin % | -56.6 | -18.3 |
| Rev Growth 5Y % | 0.3 | 3.8 |
| D/E | 0.0 | 0.4 |
Analyst Price Target
5 analysts
Buy
Current
$0.52
Target
$2.10
$1.00
$2.50
$3.00
Forecast
Forward P/E
0.81
Forward EPS
$0.64
EPS Growth (est.)
+413.6%
Est. Revenue
319.10 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.64
$0.04 – $1.25
|
319.10 M | 2 |
| FY2026 |
$0.13
-$0.44 – $0.69
|
298.91 M | 2 |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 |
-$0.01
-$0.15 – $0.13
|
73.04 M | 2 |
| 2026 Q1 |
-$0.06
-$0.22 – $0.10
|
72.43 M | 2 |
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q42025 | -$0.34 | -$1.68 | -390.0% |
| Q32025 | -$0.40 | -$0.25 | +38.5% |
| Q22025 | -$0.23 | -$0.21 | +7.1% |
| Q12025 | $0.03 | -$0.17 | -622.1% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -47.74% | Revenue Growth (3Y) | -28.16% |
| Earnings Growth (1Y) | -1465.21% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0.27% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 322.20 M | Net Income (TTM) | -182.40 M |
| ROE | -64.25% | ROA | -47.87% |
| Gross Margin | N/A | Operating Margin | -55.26% |
| Net Margin | -56.61% | Free Cash Flow (TTM) | 29.91 M |
| ROIC | -47.81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 2.59 |
| Interest Coverage | N/A | Asset Turnover | 0.85 |
| Working Capital | 116.64 M | Tangible Book Value | 211.50 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.31 | Forward P/E | N/A |
| P/B Ratio | 0.21 | P/S Ratio | 0.18 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 52.74% | ||
| Market Cap | 56.71 M | Enterprise Value | -16.39 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.84 | Revenue / Share | 3.26 |
| FCF / Share | 0.30 | OCF / Share | 0.35 |
| EPS CAGR (1Y) | -1122.22% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1.41% | FCF Conversion | -16.40% |
| SBC-Adj. FCF | 12.45 M | Growth Momentum | -48.01 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 322.20 M | 616.56 M | 624.29 M | 440.52 M | — |
| Net Income | -182.40 M | 13.36 M | 10.05 M | 34.58 M | -148,751.0 |
| EPS (Diluted) | -1.84 | 0.18 | 0.06 | 0.34 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -178.03 M | 28.69 M | 15.05 M | 21.83 M | -168,830.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 13.56 M | 11.59 M | 10.86 M | 5.38 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 15.66 M | 15.88 M | 4.83 M | 10.57 M | — |
| Interest Expense | — | — | 1.68 M | 117,664.0 | — |
| Income Tax | 8.87 M | 14.39 M | 6.36 M | -7.96 M | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 217.10 M | 455.62 M | 490.45 M | 393.28 M | 116.07 M |
| Total Liabilities | 91.23 M | 140.44 M | 185.28 M | 114.35 M | 4.18 M |
| Shareholders' Equity | 144.01 M | 320.92 M | 300.79 M | 273.23 M | 5.00 M |
| Total Debt | 235,583.0 | 17,730.0 | 69,717.0 | — | — |
| Cash & Equivalents | 51.02 M | 89.24 M | 59.29 M | 157.34 M | 878,653.0 |
| Current Assets | 152.40 M | 304.49 M | 338.87 M | 271.08 M | 1.05 M |
| Current Liabilities | 67.49 M | 121.81 M | 170.12 M | 100.16 M | 159,850.0 |
{"event":"ticker_viewed","properties":{"ticker":"DCGO","listing_kind":"stock","pathname":"/stocks/dcgo","exchange":"Nasdaq","country":"US"}}




